A Synthetic Tul4 and FopA Peptide Cocktail of Francisella tularensis Induces Humoral and Cell-Mediated Immune Responses in Mice |
Oh, Hanseul
(Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University)
Kim, C-Yoon (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) Kim, Chang-Hwan (The 5th R&D Institute-3, Agency for Defense Development) Hur, Gyeung-Haeng (The 5th R&D Institute-3, Agency for Defense Development) Park, Jae-Hak (Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University) |
1 | Ashtekar AR, Katz J, Xu Q, Michalek SM. 2012. A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS. PLoS One 7: e50460. DOI |
2 | Conlan JW. 2011. Tularemia vaccines: recent developments and remaining hurdles. Future Microbiol. 6: 391-405. DOI |
3 | Cristillo AD, Wang S, Caskey MS, Unangst T, Hocker L, He L, et al. 2006. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine. Virology 346: 151-168. DOI |
4 | Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285: 2763-2773. DOI |
5 | Huntley JF, Conley PG, Rasko DA, Hagman KE, Apicella MA, Norgard MV. 2008. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis. Infect. Immun. 76: 3664-3671. DOI |
6 | Diehl S, Rincon M. 2002. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 39: 531-536. DOI |
7 | Gregory SH, Mott S, Phung J, Lee J, Moise L, McMurry JA, et al. 2009. Epitope-based vaccination against pneumonic tularemia. Vaccine 27: 5299-5306. DOI |
8 | Hickey AJ, Hazlett KR, Kirimanjeswara GS, Metzger DW. 2011. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Vaccine 29: 6941-6947. |
9 | Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. 1998. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161: 3042-3049. |
10 | Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW. 2008. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol. Rev. 225: 244-255. DOI |
11 | Kweon MN, Fujihashi K, VanCott JL, Higuchi K, Yamamoto M, McGhee JR, Kiyono H. 1998. Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice. J. Immunol. 160: 1687-1693. |
12 | Li W, Joshi M, Singhania S, Ramsey K, Murthy A. 2014. Peptide vaccine: progress and challenges. Vaccines 2: 515. DOI |
13 | Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, et al. 1995. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154: 5071-5079. |
14 | Roberts LM, Ledvina HE, Sempowski GD, Frelinger JA. 2014. TLR2 signaling is required for the innate, but not adaptive response to LVS clpB. Front. Immunol. 5: 426. |
15 | Morecki S, Gelfand Y, Yacovlev E, Eizik O, Shabat Y, Slavin S. 2008. CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy. Biol. Blood Marrow Transplant. 14: 973-984. DOI |
16 | Valentino MD, Hensley LL, Skrombolas D, McPherson PL, Woolard MD, Kawula TH, et al. 2009. Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS. Mol. Immunol. 46: 1830- 1838. DOI |
17 | Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6: 769-776. DOI |
18 | Park SJ, Nakagawa T, Kitamura H, Atsumi T, Kamon H, Sawa S, et al. 2004. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 173: 3844-3854. DOI |
19 | Thakran S, Li H, Lavine CL, Miller MA, Bina JE, Bina XR, Re F. 2008. Identification of Francisella tularensis lipoproteins that stimulate the Toll-like receptor (TLR) 2/TLR1 heterodimer. J. Biol. Chem. 283: 3751-3760. DOI |
20 | Wang BZ, Xu R, Quan FS, Kang SM, Wang L, Compans RW. 2010. Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection. PLoS One 5: e13972. DOI |
21 | Wingender G, Garbi N, Schumak B, Jungerkes F, Endl E, von Bubnoff D, et al. 2006. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur. J. Immunol. 36: 12-20. DOI |
22 | Zhou W, Li Y, Pan X, Gao Y, Li B, Qiu Z, et al. 2013. Toll-like receptor 9 interaction with CpG ODN - an in silico analysis approach. Theor. Biol. Med. Model. 10: 18. DOI |